3E2-29132-26931
4 vaccinations
6 coded responses
48 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 191 / PA
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Moderna
-
2021-03-03
Registered in v-safe
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness · Fatigue or tirednessAdult check-in
- 2021-03-06
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: GoodFree text: Started Norvasc 5 mg todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
-
2021-03-15
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus — Feeling: FairFree text: Redness and itching on arm near vaccination site at day 9 post-vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — day 21, dose 1MedDRA: Hidradenitis — Feeling: GoodFree text: Severe hidradenitis suppurativa outbreak in week 2 following vaccination. Symptoms continue but are improving with doxycycline.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Dose 2 — Moderna
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint painsAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
-
2021-06-25
Survey response — 3 months, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: Extended seasonal allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-24
-
2021-11-23
Dose 3 — Moderna
-
2021-11-23
Survey response — day 0, dose 3MedDRA: Headache — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-07
- 2021-12-14
-
2021-12-21
Survey response — day 28, dose 3MedDRA: Menopause, Menstruation irregular — Feeling: GoodFree text: Menstrual period arrived one week early. (Likely due to peri menopause, but thought I would report anyway, as this has not happened before.)MedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
- 2022-01-04
- 2022-02-22
- 2022-05-24
-
2022-09-12
Dose 4 — Pfizer-BioNTech
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Moderna | |
| 2 | 2021-03-26 | Moderna | |
| 3 | 2021-11-23 | Moderna | No |
| 4 | 2022-09-12 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Started Norvasc 5 mg today
Release 5 — day 14, dose 1
Symptoms: Redness and itching on arm near vaccination site at day 9 post-vaccine.
Release 6 — day 21, dose 1
Symptoms: Severe hidradenitis suppurativa outbreak in week 2 following vaccination. Symptoms continue but are improving with doxycycline.
Release 9 — 3 months, dose 2
Symptoms: Extended seasonal allergies.
Release 10 — day 0, dose 3
Systemic reaction (other): Headache
Release 10 — day 28, dose 3
Symptoms: Menstrual period arrived one week early. (Likely due to peri menopause, but thought I would report anyway, as this has not happened before.)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hidradenitis | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Menopause | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release